Transformation into SCLC represents a rare mechanism of resistance to EGFR-TKIs in advanced lung adenocarcinoma harboring EGFR mutations, accounting for approximately 5-15% of resistance etiologies (35, 36). Here, EGFR is linked to lung adenocarcinoma.